Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness

14 Mar 2023

Abstract excerpt

BACKGROUND: Group B Streptococcus (GBS) can cause invasive disease (iGBS) in young infants, typically presenting as sepsis or meningitis, and is also associated with stillbirth and preterm birth. GBS vaccines are under development, but their potential health impact and cost-effectiveness have not been assessed globally. METHODS AND FINDINGS: We assessed the health impact and value (using net monetary benefit...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neonatal and Maternal Infections
Share to Preterm Birth and Chorioamnionitis
Share to Sepsis Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36917564
DOI: 10.1371/journal.pmed.1004068

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectivenessPMID 36917564Read ↗

Acceptability and feasibility of maternal screening for Group B Streptococcus: a rapid reviewSemantic proximity Read ↗

Clinical and regulatory development strategies for GBS vaccines intended for maternal immunisation in low- and middle-income countriesSemantic proximity Read ↗

Maternal and neonatal outcomes of Group B Streptococcus colonization: a retrospective studySemantic proximity Read ↗

Potential for Maternally Administered Vaccine for Infant Group B StreptococcusSemantic proximity Read ↗

Serological thresholds of risk reduction for infant group B streptococcus diseaseSemantic proximity Read ↗

Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult womenSemantic proximity Read ↗

Recommendations for the Prevention of Perinatal Group B Streptococcal (GBS) DiseaseSemantic proximity Read ↗

An empirical Bayes method for serotype case-carrier ratios, with an application to Group B streptococcusSemantic proximity Read ↗

Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan.Semantic proximity Read ↗

Vaccine effectiveness against mild and severe disease in pregnant mothers and their infants in EnglandSemantic proximity Read ↗

Standardized country-level delivery unit cost estimates for routine childhood, routine adolescent, and campaign vaccination: an updated modeling analysisSemantic proximity Read ↗

Human systemic and mucosal immune responses support further exploration of a <i>Klebsiella pneumoniae</i> protein-based vaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.